Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Metsä Board raises its result guidance for October–December 2017

Metsä Board Corporation Stock Exchange Release 13 December 2017 at 10.00 EETMetsä Board is raising its result guidance for the fourth quarter of 2017, which was announced in Metsä Board’s interim report for January–September 2017. The previous guidance was: Mainly due to the maintenance shutdown at the Husum integrated mill, Metsä Board’s comparable operating result in the fourth quarter of 2017 is expected to weaken slightly from the third quarter of 2017. The new guidance is: Metsä Board’s comparable operating result in the fourth quarter of 2017 is expected to remain roughly at the

SimCorp Ends 2017 With a Host of Industry Accolades for its Services to the Global Asset Management Industry

SimCorp , a leading provider of investment management solutions  and services to the global financial services industry, today announces its latest industry accolade, the award for Best Fund Accounting, Portfolio Management & Data Platform at the Data Management Review Awards 2017. The awards ceremony, which took place last Friday, honored SimCorp’s commitment to the financial services industry with its innovative investment management solution, SimCorp Dimension, and in particular the suite of software and services that solve the data

Two year extension of the Manja licence with flexible work program

Crown Energy AB (“Crown Energy”) are pleased to announce an extension to our 100% owned Block 3108 Manja Licence, onshore Madagascar.Following a meeting with OMNIS, the regulatory body of Madagascar it has been agreed to extend the exploration period for two years until 14-Nov-19.  The work programme for this additional two year phase is carried over from the previous period and will continue to consist of an FTG (Full Tensor Gravity) survey over the block, followed by optional 2D seismic.  The two year phase will contemplate drilling of the first exploration well. The agreement had a

Oboya Horticulture change MTF list to Nasdaq First North and publish company description

Oboya Horticulture Industries AB (publ) (”Oboya Horticulture” or “the Company”) has applied for, and received, conditional approval for trading on Nasdaq First North. The first trading day for the Company’s shares on Nasdaq First North will be December 18th, 2017. Trading with the Company’s share on AktieTorget will be terminated and the last trading on AktieTorget will be December 15th, 2017. “The listing on Nasdaq First North is an important step on Oboya Horticulture’s growth journey. Nasdaq is a global and well-known brand, which enables increased visibility on the financial market

Share-based incentive programme in Momentum Group AB (publ) fully subscribed

The share-based incentive programme for key individuals in senior positions in the Momentum Group comprising call options for repurchased Class B shares, which was adopted by the Extraordinary General Meeting of Shareholders held on 28 November 2017, is now fully subscribed. The programme encompasses 40 employees, who have subscribed for a combined total of 250,000 call options. The call options will be conveyed at a price of SEK 9.60 per call option, equivalent to the market value of the options according to a valuation performed by Nordea Bank AB (publ). The redemption price for the

NeuroVive’s KL1333 program granted orphan drug designation by the European Commission

Lund, Sweden, 13 December 2017 – NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), announced today that the European Commission has granted orphan drug designation (ODD) for the company’s KL1333 program for oral treatment of the genetic mitochondrial disease Mitochondrial Myopathy, Encephalopathy, Lactic acidosis and Stroke-like episodes (MELAS).The decision by the Commission confirms the opinion previously issued by the European Medicine Agency’s (EMA) Committee for Orphan Medicinal Products (COMP), which was communicated by NeuroVive on 8 November 2017. The orphan drug

Arkessa, Brighter, Ericsson and Gemalto partner to provide global connectivity solutions for Actiste.

Brighter AB have selected the Arkessa eUICC solutions to support the global market launch of Actiste, a mobile health solution that simplifies insulin-treated diabetes by gathering and sharing personal health data between patient and healthcare professionals through a connected pocket-sized device. Actiste will be marketed and sold as a service to both consumers and the healthcare sector across the globe. The flexibility offered by eUICC is critical to simplifying the go-to-market process and the customer experience by ensuring out-of-the-box connectivity, but also localising that

New report considers how organizations canincrease their Corporate IQ and profits with an AI-First model

Organizations today should place Artificial Intelligence (AI) at the heart of their digital strategies, according to a new report from SogetiLabs.Paris/Stockholm, France/Sweden, 13th December, 2017 – The last in a series of four qualitative research reports on the topic of Machine Intelligence, ‘AI First: Learning from the machine’  states that profit and economic growth go hand in hand with the proactive deployment of AI. It further asserts that companies can raise their Corporate IQ by embarking on a new

Update on C-RAD delivery of its advanced surface tracking solution to Swedish Cancer Center Nya Karolinska Solna

C-RAD announced in August that a contract to supply Nya Karolinska Solna (NKS) and Södersjukhuset in Stockholm, Sweden with its latest SIGRT (Surface Image Guided Radiation Therapy) solution was signed with Elekta Instruments AB, the Swedish subsidiary of Elekta AB (publ). C-RAD wants to give an update on this project. C-RAD is aware of the information that has been published by Elekta on December 12, 2017 with regards to the Letter of Intent on the supply of cancer care equipment to the center Nya Karolinska Solna and Södersjukhuset in Stockholm. The background is a public tender

Notification according to chapter 9, section 5 and 6 of the Securities Market Act: BlackRock, Inc ownership in Valmet decreased to below 5 percent

Valmet Oyj's stock exchange release on December 13, 2017 at 9:30 a.m. EET Valmet Oyj has on December 12, 2017 received a notification referred to in Securities Market Act from BlackRock, Inc, stating that the company's ownership and share of votes in Valmet Oyj has fallen below the threshold of 5 percent. As a result of share transactions on December 11, 2017, the holding of BlackRock, Inc decreased to below 5 percent of Valmet Oyj's total number of shares and share of votes. Valmet Oyj has one series of shares in which each share carries one vote. The aggregate number of shares is

Axactor Group secures significant consumer portfolio in Italy

Oslo, 13th December 2017 - Axactor Italy, an Axactor group company, has acquired a significant portfolio of unsecured consumer claims from a large financial institution in Italy. The portfolio has an outstanding balance of approximately EUR 90m across 20.000 cases and represents Axactor's largest acquisition in Italy since acquiring CS Union in 2016. This acquisition will generate an increase in the volumes of cases under management and will benefit both the amicable and legal workstreams, which are both very important in Italy. Massimiliano Ciferri, country manager Italy, commented "

BONESUPPORT™ ACHIEVES AIM OF RECRUITING 136 PATIENTS INTO THE CERTiFy STUDY COMPARING CERAMENT®|BONE VOID FILLER WITH AUTOGRAFT

Lund, Sweden, 08.00 CET, 13 December 2017 – BONESUPPORT™, an emerging leader in innovative injectable bio-ceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery based on its unique CERAMENT® platform today announces that it has achieved its aim of recruiting 136 patients into the CERTiFy (CERAMENT® Treatment of Fracture defects) study.   CERTiFY is a prospective, randomized, controlled clinical study designed to compare the differences in pain, quality of life, and cost of care in the treatment of tibia plateau fracture-associated

Invitation to Basware’s Capital Markets Day 2018

Basware Corporation, press release, December 13, 2017 at 9:00amInvitation to Basware’s Capital Markets Day 2018 Basware Corporation is pleased to invite interested analysts and institutional investors to its Capital Markets Day, to be held in London, UK, on February 9, 2018. The event will be held at Mondrian London (address: 20 Upper Ground). The event starts at 8:30am and will end at approximately 2pm. The purpose of the Capital Markets Day is to provide analysts and investors an opportunity to hear from the company’s executive management, including Vesa Tykkyläinen (CEO), Niclas

The Swedish Competition Authority has approved Instalco’s acquisition of Elkontakt i Borås

Instalco has received approval from the Swedish Competition Authority to acquire Elkontakt i Borås AB and all subsidiaries in the Elkontakt group. Hence, the acquisition will take place within five business days.Elkontakt currently employs approx. 80 people and is a complete provider of electrical, telecommunications and data installation services. The company has specialty expertise in installations at new construction projects, primarily in logistics centres, warehouse and production plants, and apartments. For the financial year that ended in August 2017, net sales amounted to approx.

Idogen has been granted a patent in the USA for its immune therapy technology

Idogen AB (”Idogen”) today announces that the United States Patent & Trademark Office (”USPTO”) has granted a patent covering the company’s technology for tolerogenic immune therapy. This technology forms the basis of the new therapies developed by Idogen to prevent the immune system from disabling the standard treatment of hemophilia, as well as causing rejection of transplanted organs. Patents in the same patent family have previously been granted in Japan and in Europe. The new patent in USA will provide Idogen’s immune therapy technology with important and broad protection in a key market

Ferronordic’s Board has decided to convert ordinary shares of series 2 to ordinary shares

Press ReleaseStockholm, 13 December 2017On 29 September 2017, Ferronordic Machines AB (publ) (“Ferronordic”) announced an offer to the holders of A-preference shares to convert their shares to ordinary shares. The company also published a prospectus regarding the offer. The application period for the conversion offer was 2–10 October 2017. In order to complete the conversion in accordance with the terms for the offer, the board of Ferronordic has decided to convert all 3,199,101 ordinary shares of series 2 in Ferronordic, which were issued within the scope of the conversion offer, to

Metsä Wood to invest in Kerto LVL production in Punkaharju

Metsä Group Press release 13 December 2017Metsä Wood, a part of Metsä Group, has decided to build a new Kerto® LVL production line, with an annual capacity of 65,000 cubic metres, at its Punkaharju mill. The value of the investment is approximately EUR 52 million. The expansion of the mill will begin in early January 2018, and the new line will start up during the first half of 2019. Agreement has been reached on the preconditions for the investment with the city of Savonlinna and the mill’s employees. The mill will be expanded by around 13,000 square metres, and the extension will be

Aker Solutions Wins Modifications Contract From Maersk Drilling

December 13, 2017 - Aker Solutions won an order from Maersk Drilling to modify the production module on the Mærsk Inspirer jack-up rig for the Repsol-operated Yme oilfield offshore Norway. The order is valued at about NOK 1 billion and will be booked in the fourth quarter. The work scope covers engineering, procurement, construction, installation and commissioning services. The North Sea Yme field was closed in 2001 after five years of production and is now being redeveloped by the operator Repsol. "We look forward to working with Maersk Drilling to ensure a successful and cost-

Ratos: Jonas Wiström new CEO of Ratos, Per-Olof Söderberg new Chairman of the Board

Press release 13 December 2017 This information is information that Ratos AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out below, at 7:45 a.m. CET on 13 December 2017. Ratos's Board of Directors has appointed current Chairman of the Board, Jonas Wiström, as the company's new CEO as of 13 December 2017. In conjunction with this change, Magnus Agervald will step down from Ratos effective immediately. The Board of Directors has appointed Per-Olof Söderberg as

UPM concluded the sale of its hydro power facilities in Schongau and Ettringen to erdgas schwaben

(UPM, Helsinki, 13 December 2017 at 08:30 EET) - UPM concluded the sale of its hydro power facilities in Schongau and Ettringen, Germany to erdgas schwaben gmbh, a regional energy company located in Augsburg, with the effective date on 31 December 2017. The transaction was announced in March 2017.  For further information please contact:Rainer Häring, Director Energy, Western Europe, UPM Paper ENA, tel. +49 173 9001470Klaus-Peter Dietmayer, Managing

IRRAS announces voluntary recall on its IRRAflow™ device due to an isolated incident of a battery manufacturing failure

IRRAS AB (IRRAS), a commercial-stage medical technology company focused on designing, developing and commercializing innovative solutions for various brain pathologies, announces that it has notified customers of a voluntary recall and a temporary stop of selling of IRRAflow™, the company’s closed-circuit medical device for the treatment of intracranial bleedings. The reason for the voluntary recall is that the battery, supplied by a well validated external manufacturer, overheated on an IRRAflow™ control unit while charging in standby mode during a routine office demonstration. No patients

NCC increases provisions in construction and civil engineering projects and reduces overhead costs

NCC’s earnings for the fourth quarter will be charged with SEK 315 million for increased provisions in construction and civil engineering projects. This adjustment entails that the project portfolios in the construction and civil engineering operations will have a lower and more balanced risk. Earnings will also be charged with SEK 75 million regarding restructuring costs for reducing overhead costs and severance pay for the former CEO. Operating profit for the fourth quarter is expected to be close to zero.The Acting Business Area Manager of NCC Infrastructure, Göran Landgren has

Read original

Targovax to present at DNB healthcare conference

Oslo, Norway, 13 December 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that members of its senior management will present a corporate overview at the following conference: DNB Nordic Healthcare conferenceDate: 14 December 2017Participants: Øystein Soug (CEO), Magnus Jäderberg (CMO) and Erik Wiklund (CFO)Presentation time: 09:30 CETVenue: DNB, Oslo The presentation will be available to download at www.targovax.com following these events. For further information, please contact:

SDRL - Changes to the Board of Directors

Hamilton, Bermuda, December 13, 2017 - Seadrill Limited ("Seadrill" or the "Company") announces today that Harald Thorstein has been appointed as Director of the Company with immediate effect. Mr Thorstein brings a wealth of relevant experience to the Company having worked extensively in the offshore and shipping industries. Harald Thorstein has served as a director of Seadrill Partners LLC since September 2012.  Mr. Thorstein is currently employed by Seatankers Consultancy Services (UK) Limited (previously Frontline Corporate Services) in London, prior to which he was employed in the

There are no items matching the current filter
There are no more items matching the current filter
Back to top